You have no items in your shopping cart.
RecombinantIGF-BP-4,His,Human [orb1494644]> 95% as analyzed by SDS-PAGE.
30-35 kDa, observed by reducing SDS-PAGE.
HEK 293
50 μg, 10 μg, 1 mg- RecombinantIGF-BP-2,His,Human [orb1494645]
> 95% as analyzed by SDS-PAGE.
6-20 kDa, observed by reducing SDS-PAGE.
HEK 293
50 μg, 10 μg, 1 mg - RecombinantLR3-IGF-I(ReceptorGrade),Human [orb1494802]
> 95% by SDS-PAGE.
9.1±0.9 KDa, observed by reducing SDS-PAGE.
Escherichia coli.
100 μg, 1 mg - RecombinantIGF-II,Human [orb1494836]
> 95% as analyzed by SDS-PAGE and HPLC.
7.6 kDa, observed by reducing SDS-PAGE.
Escherichia coli.
50 μg, 10 μg, 1 mg - RecombinantIGF-I,Rat [orb1494837]
> 95% as analyzed by SDS-PAGE and HPLC.
7.8 kDa, observed by reducing SDS-PAGE.
Escherichia coli.
50 μg, 10 μg, 1 mg - RecombinantIGF-I,Mouse [orb1494838]
> 95% by SDS-PAGE analysis.
7.8 kDa, observed by reducing SDS-PAGE.
Escherichia coli.
50 μg, 10 μg, 1 mg - RecombinantIGF-I,Human [orb1494839]
> 95% by SDS-PAGE and HPLC analyses.
7.7 kDa, observed by reducing SDS-PAGE.
Escherichia coli.
50 μg, 10 μg, 1 mg - RecombinantIGF-I(N-Met),Human [orb1494840]
> 95% as analyzed by SDS-PAGE.
7.8 kDa, observed by reducing SDS-PAGE.
Escherichia coli.
50 μg, 10 μg, 1 mg - RecombinantGH,Human [orb1494858]
> 95% by SDS-PAGE and HPLC analyses.
22.1 kDa, observed by reducing SDS-PAGE.
Escherichia coli.
50 μg, 10 μg, 1 mg